MEDZON TAB (Pioglitazone Tablets 30/45 mg)
MEDZON TAB (Pioglitazone Tablets 30/45 mg)
HBAIC & Lipid Level stabilizer
In Type 2 Diabetic Individuals with insulin Resistance & Beta Cell Dysfuntion......
- Effectively decrease blood glycosylated haemoglobin (HbA1C) levels in Patients with Poorly Controlled type 2 diabetes mellitus.
- Reduces major adverse Cardiovascular events in patients with insulin resistance, Pre diabetes and diabetes mellitus.
- Superior to glicalzide in sustaining glycemic Control in patients with type 2 diabetes.
- Effective as monotherapy and in combination with other treatments, in producing Significant falls in HbA1C and favorable improvements in lipid Parametes.
INDICATIONS:
- In Type 2 Diabetes with Insulin resistance & Beta Cell Dysfuntion
